| PSMC5 |
blood microparticle |
GO:0072562 |
| PSMC5 |
cytoplasm |
GO:0005737 |
| PSMC5 |
cytoplasmic vesicle |
GO:0031410 |
| PSMC5 |
cytosol |
GO:0005829 |
| PSMC5 |
cytosolic proteasome complex |
GO:0031597 |
| PSMC5 |
extracellular exosome |
GO:0070062 |
| PSMC5 |
inclusion body |
GO:0016234 |
| PSMC5 |
membrane |
GO:0016020 |
| PSMC5 |
nuclear proteasome complex |
GO:0031595 |
| PSMC5 |
nucleoplasm |
GO:0005654 |
| PSMC5 |
nucleus |
GO:0005634 |
| PSMC5 |
postsynapse |
GO:0098794 |
| PSMC5 |
proteasome accessory complex |
GO:0022624 |
| PSMC5 |
proteasome complex |
GO:0000502 |
| PSMC5 |
proteasome regulatory particle, base subcomplex |
GO:0008540 |
| PSMC5 |
ATP binding |
GO:0005524 |
| PSMC5 |
ATPase activity |
GO:0016887 |
| PSMC5 |
TBP-class protein binding |
GO:0017025 |
| PSMC5 |
thyrotropin-releasing hormone receptor binding |
GO:0031531 |
| PSMC5 |
transcription factor binding |
GO:0008134 |
| PSMC5 |
anaphase-promoting complex-dependent catabolic process |
GO:0031145 |
| PSMC5 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent |
GO:0002479 |
| PSMC5 |
Fc-epsilon receptor signaling pathway |
GO:0038095 |
| PSMC5 |
interleukin-1-mediated signaling pathway |
GO:0070498 |
| PSMC5 |
MAPK cascade |
GO:0000165 |
| PSMC5 |
modulation of chemical synaptic transmission |
GO:0050804 |
| PSMC5 |
negative regulation of canonical Wnt signaling pathway |
GO:0090090 |
| PSMC5 |
negative regulation of G2/M transition of mitotic cell cycle |
GO:0010972 |
| PSMC5 |
negative regulation of programmed cell death |
GO:0043069 |
| PSMC5 |
negative regulation of transcription, DNA-templated |
GO:0045892 |
| PSMC5 |
NIK/NF-kappaB signaling |
GO:0038061 |
| PSMC5 |
positive regulation of canonical Wnt signaling pathway |
GO:0090263 |
| PSMC5 |
positive regulation of inclusion body assembly |
GO:0090261 |
| PSMC5 |
positive regulation of RNA polymerase II transcription preinitiation complex assembly |
GO:0045899 |
| PSMC5 |
positive regulation of transcription, DNA-templated |
GO:0045893 |
| PSMC5 |
post-translational protein modification |
GO:0043687 |
| PSMC5 |
proteasome-mediated ubiquitin-dependent protein catabolic process |
GO:0043161 |
| PSMC5 |
protein deubiquitination |
GO:0016579 |
| PSMC5 |
protein polyubiquitination |
GO:0000209 |
| PSMC5 |
regulation of cellular amino acid metabolic process |
GO:0006521 |
| PSMC5 |
regulation of hematopoietic stem cell differentiation |
GO:1902036 |
| PSMC5 |
regulation of mitotic cell cycle phase transition |
GO:1901990 |
| PSMC5 |
regulation of mRNA stability |
GO:0043488 |
| PSMC5 |
regulation of transcription by RNA polymerase II |
GO:0006357 |
| PSMC5 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia |
GO:0061418 |
| PSMC5 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process |
GO:0031146 |
| PSMC5 |
stimulatory C-type lectin receptor signaling pathway |
GO:0002223 |
| PSMC5 |
T cell receptor signaling pathway |
GO:0050852 |
| PSMC5 |
transmembrane transport |
GO:0055085 |
| PSMC5 |
tumor necrosis factor-mediated signaling pathway |
GO:0033209 |
| PSMC5 |
Wnt signaling pathway, planar cell polarity pathway |
GO:0060071 |